A lethal case of hoarding due to the combination of traumatic and confined space asphyxia - Cappelletti S, Cipolloni L, Piacentino D, Aromatario M.
We describe a case of a woman who died from a combined trauma... (Source: SafetyLit)
Source: SafetyLit - December 15, 2018 Category: International Medicine & Public Health Tags: Drowning, Suffocation Source Type: news

SC stalls IHH's acquisition of Fortis Healthcare
Daiichi argued on Friday that the IHH-Fortis deal would impact the enforcement of its arbitration award against the Singhs, according to one of the lawyers cited earlier. (Source: The Economic Times)
Source: The Economic Times - December 15, 2018 Category: Consumer Health News Source Type: news

54 digital health mergers and acquisitions in 2018
From Amazon's acquisition of PillPack to Best Buy's purchase of GreatCall, over $7.5 billion were spent on digital health acquisitions this year. (Source: mobihealthnews)
Source: mobihealthnews - December 14, 2018 Category: Information Technology Source Type: news

MiMedx escapes Osiris trade theft suit
MiMedx (NSDQ:MDXG) enjoyed a rare spot of good news when a federal judge in Maryland this week dismissed a trade theft and breach-of-contract lawsuit brought by Osiris Therapeutics over MiMedx’s  Stability Biologics acquisition. Columbia, Md.-based Osiris said it inked a distribution deal back in 2013 to have Stability sell a pair of its products through the end of 2015. But after MiMedx paid $10 million for Stability in January 2016, it allegedly gained access to Osiris trade secrets and fostered a series of events leading to $6.8 million in losses for Osiris. (In an...
Source: Mass Device - December 14, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Legal News Regenerative Medicine MiMedx Group Inc. Osiris Therapeutics Inc. Source Type: news

WellSky will add 100 employees with latest acquisition
WellSky, backed by TPG Capital, will add 100 employees nationwide and create momentum for more jobs in Kansas City and Lenexa through its latest acquisition, CEO Bill Miller said.   Formerly Mediware Information Systems Inc., the Lenexa-based health software company acquired Consolo Services Group Inc., expanding its reach in the hospice industry to the palliative care, adult day care and memory care markets.  Consolo CEO Greg Kite will continue to lead his team at its he adquarters in Lexington,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 14, 2018 Category: Pharmaceuticals Authors: Lily Lieberman Source Type: news

California and New York approve Cigna/Express Scripts deal
California Department of Managed Health Care (DMHC) and New York's Department of Financial Services (NYDFS) on Thursday approved the $54 billion merger between Cigna and Express Scripts. Both states approved the deal and listed a set of conditions that the companies agreed to. Per the DMHC’s approval, Cigna and Express Scripts agree to not increase premiums as a result of acquisition costs, and keep premium rate increases to a minimum. Both companies have agreed to invest $60 million in California’s… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 14, 2018 Category: Pharmaceuticals Authors: Brian Robbins Source Type: news

Moody ’ s: Outlook strong for medical devices in 2019
The medical device industry should see a stand-out year in 2019, according to a Moody’s report on the industry, Medtech Dive reports. The financial services company predicts a positive outlook for medtech, with forecasted earnings before interest, tax, depreciation and amortization of between 4.5% and 5.5% for companies on an organic basis, according to the report. The positive outlook for medtech stands out from the rest of the healthcare field, with pharmaceuticals and U.S. for-profit hospitals only receiving a stable outlook, Medtech Dive reports. Revenue growth for device companies will be driven through inn...
Source: Mass Device - December 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Moody's Investor Service Source Type: news

Urgent care merger to affect nearly a dozen SA clinics
Nearly a dozen San Antonio-area clinics are part of the more than 250-center deal. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 14, 2018 Category: American Health Authors: W. Scott Bailey Source Type: news

Cava, Optoro and a bunch of biotechs: The top 10 venture deals of 2018
It is likely that 2018 is the best year for venture capital in recent memory. Some of the most well-known startups in Greater Washington got fresh infusions of venture capital in 2018, propelling growth and fueling acquisitions. Meanwhile some new players broke into the top ranks of VC deals, including recent spinoff Viela Bio. The top 10 deals of the year are a reminder t hat 2018 has been particularly good for larger startups. The region saw $1.42 billion in venture funding through the first three… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 14, 2018 Category: Biotechnology Authors: Andy Medici Source Type: news

Cava, Optoro and a bunch of biotechs: The top 10 venture deals of 2018
It is likely that 2018 is the best year for venture capital in recent memory. Some of the most well-known startups in Greater Washington got fresh infusions of venture capital in 2018, propelling growth and fueling acquisitions. Meanwhile some new players broke into the top ranks of VC deals, including recent spinoff Viela Bio. The top 10 deals of the year are a reminder t hat 2018 has been particularly good for larger startups. The region saw $1.42 billion in venture funding through the first three… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 14, 2018 Category: American Health Authors: Andy Medici Source Type: news

ConMed to acquire Buffalo Filter for $365m
ConMed (NSDQ:CNMD) said today that it inked a deal to acquire surgical smoke evacuation tech developer Buffalo Filter for $365 million. Buffalo Filter develops and produces surgical smoke evacuation technologies, including smoke evacuation pencils, smoke evacuators and laparoscopic solutions, ConMed said. Utica, N.Y.-based ConMed said that it expects to finance the transaction through a combination of new convertible notes and an expanded and amended credit facility. ConMed expects the acquisition to close in the first quarter of next year. “We are excited to join ConMed and continue our mission of improving saf...
Source: Mass Device - December 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Featured Mergers & Acquisitions Surgical ConMed Corp. Source Type: news

Gavin McGinnis fiasco proves tech giants use bogus “hate speech” claims to permanently ban anyone they don't like
(Natural News) The Left-wing social media behemoths are continuing their efforts to drive all influential conservative voices from their platforms, and Gavin McGinnis, founder of the Proud Boys and formerly with CRTV, has become the latest victim. Shortly after CRTV announced a merger with financially struggling TheBlazeTV, founded by Glenn Beck, McGinnis was let go/sent... (Source: NaturalNews.com)
Source: NaturalNews.com - December 13, 2018 Category: Consumer Health News Source Type: news

Control HIV by treating schistosomiasis, new study suggests
(PLOS) Of the 34 million people worldwide with HIV, and the 200 million with schistosomiasis, the majority live in Africa -- where millions of people are simultaneously infected with both diseases. Now, researchers reporting in PLOS Neglected Tropical Diseases have shown that schistosomiasis infections are associated with increased HIV onward transmission, HIV acquisition in HIV negative women with urogenital schistosomiasis, and progression to death in HIV positive women. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 13, 2018 Category: Infectious Diseases Source Type: news

High-affinity allergen-specific human antibodies cloned from single IgE B cell transcriptomes
Immunoglobulin E (IgE) antibodies protect against helminth infections but can also cause life-threatening allergic reactions. Despite their role in human health, the cells that produce these antibodies are rarely observed and remain enigmatic. We isolated single IgE B cells from individuals with food allergies and used single-cell RNA sequencing to elucidate the gene expression and splicing patterns unique to these cells. We identified a surprising example of convergent evolution in which IgE antibodies underwent identical gene rearrangements in unrelated individuals. Through the acquisition of variable region mutations, t...
Source: ScienceNOW - December 13, 2018 Category: Science Authors: Croote, D., Darmanis, S., Nadeau, K. C., Quake, S. R. Tags: Immunology reports Source Type: news

Carestream Dental Intraoral Scanners Offer New Integration with 3M ™ Oral Care Portal
ATLANTA—Doctors using Oral Care Portal to plan treatment for 3M ™ Clarity™ Aligners and Carestream Dental’s CS 3500 and CS 3600 intraoral scanners now have an easy and efficient way to submit their digital scans: A new integration that allows doctors to conveniently send their files directly to 3M through CS Imaging software version 8, using the CS Con nect portal.There ’s no need to export the case from the CS Acquisition software and then upload it through the 3M portal. Instead, the submission can be handled automatically within Carestream Dental’s software, reducing clicks and saving...
Source: Dental Technology Blog - December 12, 2018 Category: Dentistry Source Type: news

BEHIND THE DEAL: BrightSpring CEO lays out strategy behind PharMerica merger
BrightSpring Health Services CEO Jon Rousseau will lead the combined company. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - December 12, 2018 Category: Health Management Authors: Chris Larson Source Type: news

BEHIND THE DEAL: BrightSpring CEO lays out strategy behind PharMerica merger
BrightSpring Health Services CEO Jon Rousseau will lead the combined company. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 12, 2018 Category: Biotechnology Authors: Chris Larson Source Type: news

Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets
Company Initiates Voluntary Chapter 11 Process to Effectuate Sale; Secures Commitment for DIP Financing to Support Normal-Course Operations NEW YORK, Dec. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP)... Biopharmaceuticals, Gastroenterology, Mergers & Acquisitions Synergy Pharmaceuticals, Bausch Health, Bausch & Lomb, TRULANCE, plecanatide (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 12, 2018 Category: Pharmaceuticals Source Type: news

UPMC to close eastern Pa. hospital
UPMC announced Tuesday it will close a hospital in Lancaster, one of the hospitals it took on in its 2017 acquisition of Pinnacle Health System. UPMC Pinnacle Lancaster's inpatient operations will move by March 2019 to UPMC Pinnacle Lititz, which is located in the town of Lititz seven miles from the location of UPMC Pinnacle Lancaster. The Lititz facility will continue to expand and UPMC Pinnacle said it would continue to have primary care and other outpatient services in Lancaster. It will also… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 12, 2018 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news

UPMC to close eastern Pa. hospital
UPMC announced Tuesday it will close a hospital in Lancaster, one of the hospitals it took on in its 2017 acquisition of Pinnacle Health System. UPMC Pinnacle Lancaster's inpatient operations will move by March 2019 to UPMC Pinnacle Lititz, which is located in the town of Lititz seven miles from the location of UPMC Pinnacle Lancaster. The Lititz facility will continue to expand and UPMC Pinnacle said it would continue to have primary care and other outpatient services in Lancaster. It will also… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 11, 2018 Category: Biotechnology Authors: Paul J. Gough Source Type: news

Feds drop insider trading, perjury charges against ex-AMO chief Mazzo
Federal prosecutors this week dropped perjury and insider trading charges against former Advanced Medical Optics CEO James Mazzo related to AMO’s $2.8 billion acquisition by Abbott (NYSE:ABT) in 2009 in light of two hung juries, according to court documents. Judge Andrew Guilford for the U.S. District Court for the Central District of California ordered a dismissal with prejudice for Mazzo this week, according to court documents. Mazzo faced charges of tipping close friend and neighbor Doug DeCinces, a former Orioles player, about AMO’s then-pending merger (Abbott subsequently...
Source: Mass Device - December 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Featured Legal News Optical/Ophthalmic Abbott Advanced Medical Optics Insider Trading Source Type: news

Shareholders approve Avista, Organogenesis tie up
Private equity firm Avista Healthcare Public Acquisition Corp. yesterday approved its merger with regenerative medicine company Organogenesis. The merger won approval yesterday at separate special meetings of shareholders for both companies, Canton, Mass.-based Organogenesis said. As part of the deal, Avista invested a total of $92 million in the combined company, Organogenesis said. Avista also said it plans to deregister in the Cayman Islands and incorporate in Delaware, according to an SEC filing. The company is slated to be run by Organogenesis’ existing management team, led by CEO Gary Gillheeney Sr., the compan...
Source: Mass Device - December 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Mergers & Acquisitions Regenerative Medicine Avista Capital Organogenesis Inc. Source Type: news

Arlington life sciences advisory firm raises $21M, buys competitor
Bioinformatics Inc. has raised $21 million in Series B funding and has already made an acquisition with the funds. The Arlington-based consulting firm, which provides research and advisory services to life science and diagnostic companies, paid $6 million to acquire Kalorama Information, a D.C.-based division of MarketResearch.com. CEO Craig Overpeck told me Kalorama's depth in clinical diagnostics research m ade it an attractive target, saying “we were kind of weak” in the space. The deal… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - December 10, 2018 Category: Health Management Authors: Sara Gilgore Source Type: news

Arlington life sciences advisory firm raises $21M, buys competitor
Bioinformatics Inc. has raised $21 million in Series B funding and has already made an acquisition with the funds. The Arlington-based consulting firm, which provides research and advisory services to life science and diagnostic companies, acquired Kalorama Information, a D.C.-based division of MarketResearch.com. Part of the new funding went toward the acquisition of Kalorama, but the companies did not disclo se terms of the deal. CEO Craig Overpeck told me Kalorama's depth in clinical diagnostics… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 10, 2018 Category: Biotechnology Authors: Sara Gilgore Source Type: news

People First: The human resources team of Lakeland Regional Health
With 5,500 people throughout Lakeland Regional Health, the human resources team has many heads to watch.   Led by Chief HR Officer Scott Dimmick, the team, referred to as the Talent Division, is structured around several tasks including talent acquisition, learning and organizational development, employee engagement, total rewards, employee benefits, talent systems and the talent service center.  T he HR team has 45 members and includes talent consultants, learning and organizational development… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 10, 2018 Category: Pharmaceuticals Authors: Pam Huff Source Type: news

People First: The human resources team of Lakeland Regional Health
With 5,500 people throughout Lakeland Regional Health, the human resources team has many heads to watch.   Led by Chief HR Officer Scott Dimmick, the team, referred to as the Talent Division, is structured around several tasks including talent acquisition, learning and organizational development, employee engagement, total rewards, employee benefits, talent systems and the talent service center.  T he HR team has 45 members and includes talent consultants, learning and organizational development… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 10, 2018 Category: Biotechnology Authors: Pam Huff Source Type: news

Fresenius Expands Presence in China With Investments and Acquisitions
Fresenius Medical Care is letting it be known that it wants to have a stronger presence in China, one of the fast-growing emerging markets. Last week the Bad Homberg, Germany-based company announced a ton of acquisitions and investments in dialysis centers and renal hospitals in China. Here’s the breakdown: The company acquired a 70% share of Guangzhou KangNiDaiSi Medical Investment Co., Ltd, which focuses on dialysis and related chronic disease services. KangNiDaiSi has three independent hemodialysis centers under construction in the cities of Guangzhou and Zhaoqing in Guangdong province, which borders H...
Source: MDDI - December 10, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Tennessee firm to buy Nutrisystem in $1.3B deal
Franklin-based Tivity Health Inc. is set to buy Pennsylvania-based weight-management company Nutrisystem Inc. in a cash-and-stock deal valued at $1.3 billion. The deal is expected to close in the first quarter. "The acquisition of Nutrisystem is an exciting and transformational event for Tivity Health as we expand our portfolio of healthy lifestyle brands," Tivity CEO Donato Tramuto said in a news release. "Tivity Health and Nutrisystem share the same mission-driven culture and have highly talented,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 10, 2018 Category: Pharmaceuticals Authors: Eric Snyder Source Type: news

Tennessee firm to buy Nutrisystem in $1.3B deal
Franklin-based Tivity Health Inc. is set to buy Pennsylvania-based weight-management company Nutrisystem Inc. in a cash-and-stock deal valued at $1.3 billion. The deal is expected to close in the first quarter. "The acquisition of Nutrisystem is an exciting and transformational event for Tivity Health as we expand our portfolio of healthy lifestyle brands," Tivity CEO Donato Tramuto said in a news release. "Tivity Health and Nutrisystem share the same mission-driven culture and have highly talented,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 10, 2018 Category: Biotechnology Authors: Eric Snyder Source Type: news

Partners gets federal approval for Care New England acquisition
Peter Markell, chief financial officer for Partners, said in an interview that the Federal Trade Commission had approved the acquisition. Partners will now seek state approval in Rhode Island. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 10, 2018 Category: Pharmaceuticals Authors: Jessica Bartlett Source Type: news

Trump Administration Halts Acquisition of Fetal Tissue for Research
Two NIH-run labs are affected, including one that seeks to cure HIV. (Source: The Scientist)
Source: The Scientist - December 10, 2018 Category: Science Tags: News & Opinion Source Type: news

Franklin firm to buy Nutrisystem in $1.3B deal
Franklin-based Tivity Health Inc. is set to buy Pennsylvania-based weight-management company Nutrisystem Inc. in a cash-and-stock deal valued at $1.3 billion. The deal is expected to close in the first quarter. "The acquisition of Nutrisystem is an exciting and transformational event for Tivity Health as we expand our portfolio of healthy lifestyle brands," Tivity CEO Donato Tramuto said in a news release. "Tivity Health and Nutrisystem share the same mission-driven culture and have highly talented,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 10, 2018 Category: Biotechnology Authors: Eric Snyder Source Type: news

Del. supremes uphold Fresenius bailout on Akorn buy
Delaware’s Supreme Court ruled last week to uphold a decision by the state’s Chancery Court that Fresenius (ETR:FRE) could walk away from its $4 billion merger with Akorn (NSDQ:AKRX). The initial deal was designed to help Fresenius move into new therapeutic areas and dosage forms, including eye drugs, ear drops, nasal sprays and respiratory drugs. But Fresenius abandoned the purchase in April, pointing at an investigation that found material breaches of FDA data integrity requirements related to Akorn’s operations. Get the full story at our sister site, Drug Delivery Business...
Source: Mass Device - December 10, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Featured Legal News Mergers & Acquisitions Pharmaceuticals Wall Street Beat Akorn Fresenius Source Type: news

Franklin firm to buy Nutrisystem in $1.3B deal
Franklin-based Tivity Health Inc. is set to buy Pennsylvania-based weight-management company Nutrisystem Inc. in a cash-and-stock deal valued at $1.3 billion. The deal is expected to close in the first quarter. "The acquisition of Nutrisystem is an exciting and transformational event for Tivity Health as we expand our portfolio of healthy lifestyle brands," Tivity CEO Donato Tramuto said in a news release. "Tivity Health and Nutrisystem share the same mission-driven culture and have highly talented,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 10, 2018 Category: American Health Authors: Eric Snyder Source Type: news

Are Medtech Companies Still Interested in M & amp;A?
Medtech companies are not that “interested” in M&A anymore, according to a survey taken during a recent MD+DI webinar discussing Medtech Trends and Adaptation. Arda Ural, Phd, a partner, transaction advisory services practice for Ernst and Young (EY) was the presenter for the webinar. When asked whether or not companies expected to pursue M&A in the coming months about 77% of the participants answered no and 23% an answered yes. This has been a strong year for mergers and acquisitions, as companies have had a lot of cash-on-hand to put to use. Boston Scientific has been one of th...
Source: MDDI - December 9, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Waltham biotech OvaScience shuts down as reverse merger closes
As part of the deal with Millendo Therapeutics, OvaScience's remaining eight employees will be laid off and the company's Waltham office will close. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 7, 2018 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

This Peninsula biotech foresaw deals worth $3 billion. Now it's lining up a $57 million merger
OncoMed Pharmaceuticals Inc. — whose wide-ranging deals around cancer stem cells once promised to bring in nearly $3 billion — will merge with a London biotech company for $57.4 million, according to terms of the transaction disclosed Wednesday. The reverse merger between Redwood City-based OncoMed and Mereo BioPharma Grou p plc will give the London company a U.S. stock listing and seven experimental drugs. If the deal closes as expected in first-half 2019, it would close the books on OncoMed… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 5, 2018 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

This Peninsula biotech foresaw deals worth $3 billion. Now it's lining up a $57 million merger
OncoMed Pharmaceuticals Inc. — whose wide-ranging deals around cancer stem cells once promised to bring in nearly $3 billion — will merge with a London biotech company for $57.4 million, according to terms of the transaction disclosed Wednesday. The reverse merger between Redwood City-based OncoMed and Mereo BioPharma Grou p plc will give the London company a U.S. stock listing and seven experimental drugs. If the deal closes as expected in first-half 2019, it would close the books on OncoMed… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 5, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

Past Covidien, ev3 Activities are Costing Medtronic a Hefty Sum
Sometimes acquiring other companies means taking the bad with the good. In Medtronic's case, that means settling multiple Department of Justice claims against ev3, a business Medtronic owns by way of its Covidien acquisition. Covidien bought ev3 in 2010 and Medtronic finalized its $49.9 billion Covidien deal in early 2015. Now, Medtronic is paying the price for activities that ev3 allegedly conducted between 2005 and 2009 involving the Onyx Liquid Embolic System. FDA approved the device in 2005 as a liquid embolization device that is surgically injected into blood vessels to block blood flow to arteriovenous malformations ...
Source: MDDI - December 5, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Subtle Medical wins FDA nod, CE Mark for SubtlePet AI-powered imaging system
Medical imaging tech developer Subtle Medical said today that it won both CE Mark approval in the European Union and FDA 510(k) clearance for its SubtlePET artificial-intelligence-powered positron emission topography imaging enhancement system. The SubtlePET system is designed to enhance images and reduce scanning times to improve overall patient experience during imaging procedures, the Menlo Park, Calif.-based company said. “Focusing Subtle Medical’s SubtlePET AI platform on faster image acquisition, we have been able to dramatically increase PET scan efficiency and provide a superior patient experience. Subt...
Source: Mass Device - December 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Featured Food & Drug Administration (FDA) Imaging Regulatory/Compliance subtlemedical Source Type: news

Medtronic to pay $51m to settle Covidien, ev3 DoJ investigations
Medtronic (NYSE:MDT) said yesterday that it agreed to pay $50.9 million to settle a number of U.S. Dept. of Justice probes into marketing activities from companies it acquired, Covidien and ev3. Medtronic said that its subsidiary ev3, acquired when the Fridley, Minn.-based medtech giant picked up Covidien in 2015, agreed to plead guilty to a misdemeanor charge related to its marketing of the Onyx Liquid Embolic System, pay $17.9 million and adopt new compliance and reporting terms for three years. The charges relate to ev3’s marketing of the device for “unproven and potentially dangerous uses,” feder...
Source: Mass Device - December 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Legal News Medtronic Source Type: news

Humana realigns C-suite and care delivery division
Humana Inc. named a new member to its C-suite and shifted oversight of a key division. Dr. Vishal Agrawal will be Humana's chief strategy and corporate development officer, starting on Dec. 10, according to a news release. Agrawal will oversee Humana's "strategic insights and planning process, establishing direction for merger, acquisition and joint venture activities, while maxim izing capabilities to create competitive advantage," according to the release. He previously was a senior adviser… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 4, 2018 Category: Pharmaceuticals Authors: Chris Larson Source Type: news

U.S. judge concerned over government nod for CVS-Aetna deal
A federal judge who has been asked to sign off on the U.S. government's decision to approve CVS Health Corp's acquisition of insurer Aetna Inc said Tuesday he was "less convinced" than the government that the companies had struck a deal that ensured the merger was legal under antitrust law. (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Is 2019 Going to Be a Standout Year for TAVR?
JenaValve has won a nod from FDA for expanded IDE enrollment of its transcatheter aortic valve replacement (TAVR) system. The agency’s nod is aimed at feasibility studies for the JenaValve Pericardial TAVR System with the Everdur transcatheter heart valve and expands eligible enrollment from 20 patients to 80 at high or extreme surgical risk. The Irvine, CA-based company said the prospective IDE studies are part of a larger, ongoing CE Mark clinical program investigating the JenaValve Pericardial TAVR System for the same indications at centers of excellence in Europe and New Zealand. Approval for addition...
Source: MDDI - December 4, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

Gaithersburg biotech names new CEO
Gaithersburg-based Altimmune Inc. has named Dr. Vipin Garg as the company ’s new president and CEO. Garg, a biotech and pharmaceutical industry veteran who most recently served as president and CEO of Texas-based Neos Therapeutics (NASDAQ: NEOS), succeeds Bill Enright, who stepped down after leading the company through more than a decade of growth involving acquisition s and an initial public offering. Garg’s appointment, including joining the board of directors, became effective Nov. 30. Altimmune… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 4, 2018 Category: American Health Authors: Sara Gilgore Source Type: news

Cross-task cue utilisation and situational awareness in simulated air traffic control - Falkland EC, Wiggins MW.
OBJECTIVE: To examine the role of cross-task cue utilisation in the acquisition of situational awareness during the initial stages of learning to operate an air traffic control simulation. BACKGROUND: Cue-based associations are an important compone... (Source: SafetyLit)
Source: SafetyLit - December 4, 2018 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Wellington, Fidelity, State Street could emerge winners from Tesaro acquisition
At an expected $75 per share, Wellington Management Co. is poised to earn the most when GlaxoSmithkline's acquisition deal for Tesaro closes. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 4, 2018 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

Longest serving hospital CEO steps down ahead of merger
The longest serving chief executive of an acute trust has announced he will step down ahead of a proposed merger of his organisation with a neighbour trust. (Source: HSJ)
Source: HSJ - December 4, 2018 Category: UK Health Source Type: news

Aclaris completes $65M deal for rosacea treatment
Malvern-based Aclaris  Therapeutics Inc. completed its previously announced $65 million acquisition of Rhofade, a rosacea treatment, from Allergan. The Food and Drug Administration approved Rhofade, a cream, last year as topical treatment of persistent facial erythema or redness associated with rosacea in adults. “ An estimated 16 million American adults have rosacea, yet only a small fraction of that number seeks professional care," said Dr. Neal Walker, president and CEO of Aclaris (NASDAQ:… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 3, 2018 Category: Biotechnology Authors: John George Source Type: news

Aclaris completes $65M deal for rosacea treatment
Malvern-based Aclaris  Therapeutics Inc. completed its previously announced $65 million acquisition of Rhofade, a rosacea treatment, from Allergan. The Food and Drug Administration approved Rhofade, a cream, last year as topical treatment of persistent facial erythema or redness associated with rosacea in adults. “ An estimated 16 million American adults have rosacea, yet only a small fraction of that number seeks professional care," said Dr. Neal Walker, president and CEO of Aclaris (NASDAQ:… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 3, 2018 Category: Pharmaceuticals Authors: John George Source Type: news